MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease

Some patients with microvillus inclusion disease due to myosin 5B (MYO5B) mutations may develop cholestasis characterized by a progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity. So far MYO5B deficiency has not been reported in patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology (Baltimore, Md.) Md.), 2017-01, Vol.65 (1), p.164-173
Hauptverfasser: Gonzales, Emmanuel, Taylor, Sarah A., Davit‐Spraul, Anne, Thébaut, Alice, Thomassin, Nadège, Guettier, Catherine, Whitington, Peter F., Jacquemin, Emmanuel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 173
container_issue 1
container_start_page 164
container_title Hepatology (Baltimore, Md.)
container_volume 65
creator Gonzales, Emmanuel
Taylor, Sarah A.
Davit‐Spraul, Anne
Thébaut, Alice
Thomassin, Nadège
Guettier, Catherine
Whitington, Peter F.
Jacquemin, Emmanuel
description Some patients with microvillus inclusion disease due to myosin 5B (MYO5B) mutations may develop cholestasis characterized by a progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity. So far MYO5B deficiency has not been reported in patients with such a cholestasis phenotype in the absence of intestinal disease. Using a new‐generation sequencing approach, we identified MYO5B mutations in five patients with progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity without intestinal disease. Conclusion: These data show that MYO5B deficiency may lead to isolated cholestasis and that MYO5B should be considered as an additional progressive familial intrahepatic cholestasis gene. (Hepatology 2017;65:164‐173).
doi_str_mv 10.1002/hep.28779
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1906440600</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4287329971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3839-eb2197d7bcf69e479f11acd77cf0aaeff42c346e6c588153e2af7306b124dfb73</originalsourceid><addsrcrecordid>eNp9kbtO7DAURS10EQyPgh9Alm5FEfAjjuMSRrwkEBRQUEWOYzNGdjLXjkHT8QEUfCNfgmHgdlCdZu21dbQB2MFoHyNEDmZ6vk9qzsUKmGBGeEEpQ3_ABBGOCoGpWAcbMT4ghERJ6jWwTjijhJXVBLxc3l2xI-jTKEc79BEqmaKGajY4HUcZbYRPdpzBfgheOhh1SB7eS-_l2_Prvcsxv3BwDLKPRgeZo1KN9tGOC2j7rLGuC7r_dAxphN6qMDxa54YUM6BcirkVdjbqnN0Cq0a6qLe_7ia4PTm-mZ4VF1en59PDi0LRmopCtwQL3vFWmUrokguDsVQd58ogKbUxJVG0rHSlWF1jRjWRhlNUtZiUnWk53QR_l955GP6l_GfzMKTQ58oGC1SVJaoQ-pWqGRGCE0Yytbek8mMxBm2aebBehkWDUfOxTpPXaT7XyezulzG1Xnf_ye85MnCwBJ6s04ufTc3Z8fVS-Q6ty52O</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1852997252</pqid></control><display><type>article</type><title>MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><creator>Gonzales, Emmanuel ; Taylor, Sarah A. ; Davit‐Spraul, Anne ; Thébaut, Alice ; Thomassin, Nadège ; Guettier, Catherine ; Whitington, Peter F. ; Jacquemin, Emmanuel</creator><creatorcontrib>Gonzales, Emmanuel ; Taylor, Sarah A. ; Davit‐Spraul, Anne ; Thébaut, Alice ; Thomassin, Nadège ; Guettier, Catherine ; Whitington, Peter F. ; Jacquemin, Emmanuel</creatorcontrib><description>Some patients with microvillus inclusion disease due to myosin 5B (MYO5B) mutations may develop cholestasis characterized by a progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity. So far MYO5B deficiency has not been reported in patients with such a cholestasis phenotype in the absence of intestinal disease. Using a new‐generation sequencing approach, we identified MYO5B mutations in five patients with progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity without intestinal disease. Conclusion: These data show that MYO5B deficiency may lead to isolated cholestasis and that MYO5B should be considered as an additional progressive familial intrahepatic cholestasis gene. (Hepatology 2017;65:164‐173).</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.28779</identifier><identifier>PMID: 27532546</identifier><identifier>CODEN: HPTLD9</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Children ; Cholestasis ; Cholestasis, Intrahepatic - blood ; Cholestasis, Intrahepatic - enzymology ; Cholestasis, Intrahepatic - genetics ; Cytomegalovirus ; Female ; Gallbladder diseases ; gamma-Glutamyltransferase - blood ; Genotype &amp; phenotype ; Hepatology ; Humans ; Infant ; Intestine ; Malabsorption Syndromes ; Male ; Microvilli - pathology ; Microvillus ; Mucolipidoses ; Mutation ; Myosin ; Myosin Heavy Chains - genetics ; Myosin Type V - genetics ; γ-Glutamyltransferase</subject><ispartof>Hepatology (Baltimore, Md.), 2017-01, Vol.65 (1), p.164-173</ispartof><rights>2016 by the American Association for the Study of Liver Diseases.</rights><rights>2017 by the American Association for the Study of Liver Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3839-eb2197d7bcf69e479f11acd77cf0aaeff42c346e6c588153e2af7306b124dfb73</citedby><cites>FETCH-LOGICAL-c3839-eb2197d7bcf69e479f11acd77cf0aaeff42c346e6c588153e2af7306b124dfb73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.28779$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.28779$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,45583,45584</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27532546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gonzales, Emmanuel</creatorcontrib><creatorcontrib>Taylor, Sarah A.</creatorcontrib><creatorcontrib>Davit‐Spraul, Anne</creatorcontrib><creatorcontrib>Thébaut, Alice</creatorcontrib><creatorcontrib>Thomassin, Nadège</creatorcontrib><creatorcontrib>Guettier, Catherine</creatorcontrib><creatorcontrib>Whitington, Peter F.</creatorcontrib><creatorcontrib>Jacquemin, Emmanuel</creatorcontrib><title>MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><description>Some patients with microvillus inclusion disease due to myosin 5B (MYO5B) mutations may develop cholestasis characterized by a progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity. So far MYO5B deficiency has not been reported in patients with such a cholestasis phenotype in the absence of intestinal disease. Using a new‐generation sequencing approach, we identified MYO5B mutations in five patients with progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity without intestinal disease. Conclusion: These data show that MYO5B deficiency may lead to isolated cholestasis and that MYO5B should be considered as an additional progressive familial intrahepatic cholestasis gene. (Hepatology 2017;65:164‐173).</description><subject>Children</subject><subject>Cholestasis</subject><subject>Cholestasis, Intrahepatic - blood</subject><subject>Cholestasis, Intrahepatic - enzymology</subject><subject>Cholestasis, Intrahepatic - genetics</subject><subject>Cytomegalovirus</subject><subject>Female</subject><subject>Gallbladder diseases</subject><subject>gamma-Glutamyltransferase - blood</subject><subject>Genotype &amp; phenotype</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Infant</subject><subject>Intestine</subject><subject>Malabsorption Syndromes</subject><subject>Male</subject><subject>Microvilli - pathology</subject><subject>Microvillus</subject><subject>Mucolipidoses</subject><subject>Mutation</subject><subject>Myosin</subject><subject>Myosin Heavy Chains - genetics</subject><subject>Myosin Type V - genetics</subject><subject>γ-Glutamyltransferase</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kbtO7DAURS10EQyPgh9Alm5FEfAjjuMSRrwkEBRQUEWOYzNGdjLXjkHT8QEUfCNfgmHgdlCdZu21dbQB2MFoHyNEDmZ6vk9qzsUKmGBGeEEpQ3_ABBGOCoGpWAcbMT4ghERJ6jWwTjijhJXVBLxc3l2xI-jTKEc79BEqmaKGajY4HUcZbYRPdpzBfgheOhh1SB7eS-_l2_Prvcsxv3BwDLKPRgeZo1KN9tGOC2j7rLGuC7r_dAxphN6qMDxa54YUM6BcirkVdjbqnN0Cq0a6qLe_7ia4PTm-mZ4VF1en59PDi0LRmopCtwQL3vFWmUrokguDsVQd58ogKbUxJVG0rHSlWF1jRjWRhlNUtZiUnWk53QR_l955GP6l_GfzMKTQ58oGC1SVJaoQ-pWqGRGCE0Yytbek8mMxBm2aebBehkWDUfOxTpPXaT7XyezulzG1Xnf_ye85MnCwBJ6s04ufTc3Z8fVS-Q6ty52O</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Gonzales, Emmanuel</creator><creator>Taylor, Sarah A.</creator><creator>Davit‐Spraul, Anne</creator><creator>Thébaut, Alice</creator><creator>Thomassin, Nadège</creator><creator>Guettier, Catherine</creator><creator>Whitington, Peter F.</creator><creator>Jacquemin, Emmanuel</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>201701</creationdate><title>MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease</title><author>Gonzales, Emmanuel ; Taylor, Sarah A. ; Davit‐Spraul, Anne ; Thébaut, Alice ; Thomassin, Nadège ; Guettier, Catherine ; Whitington, Peter F. ; Jacquemin, Emmanuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3839-eb2197d7bcf69e479f11acd77cf0aaeff42c346e6c588153e2af7306b124dfb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Children</topic><topic>Cholestasis</topic><topic>Cholestasis, Intrahepatic - blood</topic><topic>Cholestasis, Intrahepatic - enzymology</topic><topic>Cholestasis, Intrahepatic - genetics</topic><topic>Cytomegalovirus</topic><topic>Female</topic><topic>Gallbladder diseases</topic><topic>gamma-Glutamyltransferase - blood</topic><topic>Genotype &amp; phenotype</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Infant</topic><topic>Intestine</topic><topic>Malabsorption Syndromes</topic><topic>Male</topic><topic>Microvilli - pathology</topic><topic>Microvillus</topic><topic>Mucolipidoses</topic><topic>Mutation</topic><topic>Myosin</topic><topic>Myosin Heavy Chains - genetics</topic><topic>Myosin Type V - genetics</topic><topic>γ-Glutamyltransferase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gonzales, Emmanuel</creatorcontrib><creatorcontrib>Taylor, Sarah A.</creatorcontrib><creatorcontrib>Davit‐Spraul, Anne</creatorcontrib><creatorcontrib>Thébaut, Alice</creatorcontrib><creatorcontrib>Thomassin, Nadège</creatorcontrib><creatorcontrib>Guettier, Catherine</creatorcontrib><creatorcontrib>Whitington, Peter F.</creatorcontrib><creatorcontrib>Jacquemin, Emmanuel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gonzales, Emmanuel</au><au>Taylor, Sarah A.</au><au>Davit‐Spraul, Anne</au><au>Thébaut, Alice</au><au>Thomassin, Nadège</au><au>Guettier, Catherine</au><au>Whitington, Peter F.</au><au>Jacquemin, Emmanuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>2017-01</date><risdate>2017</risdate><volume>65</volume><issue>1</issue><spage>164</spage><epage>173</epage><pages>164-173</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><coden>HPTLD9</coden><abstract>Some patients with microvillus inclusion disease due to myosin 5B (MYO5B) mutations may develop cholestasis characterized by a progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity. So far MYO5B deficiency has not been reported in patients with such a cholestasis phenotype in the absence of intestinal disease. Using a new‐generation sequencing approach, we identified MYO5B mutations in five patients with progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity without intestinal disease. Conclusion: These data show that MYO5B deficiency may lead to isolated cholestasis and that MYO5B should be considered as an additional progressive familial intrahepatic cholestasis gene. (Hepatology 2017;65:164‐173).</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>27532546</pmid><doi>10.1002/hep.28779</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-9139
ispartof Hepatology (Baltimore, Md.), 2017-01, Vol.65 (1), p.164-173
issn 0270-9139
1527-3350
language eng
recordid cdi_proquest_journals_1906440600
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library
subjects Children
Cholestasis
Cholestasis, Intrahepatic - blood
Cholestasis, Intrahepatic - enzymology
Cholestasis, Intrahepatic - genetics
Cytomegalovirus
Female
Gallbladder diseases
gamma-Glutamyltransferase - blood
Genotype & phenotype
Hepatology
Humans
Infant
Intestine
Malabsorption Syndromes
Male
Microvilli - pathology
Microvillus
Mucolipidoses
Mutation
Myosin
Myosin Heavy Chains - genetics
Myosin Type V - genetics
γ-Glutamyltransferase
title MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T14%3A35%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MYO5B%20mutations%20cause%20cholestasis%20with%20normal%20serum%20gamma%E2%80%90glutamyl%20transferase%20activity%20in%20children%20without%20microvillous%20inclusion%20disease&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Gonzales,%20Emmanuel&rft.date=2017-01&rft.volume=65&rft.issue=1&rft.spage=164&rft.epage=173&rft.pages=164-173&rft.issn=0270-9139&rft.eissn=1527-3350&rft.coden=HPTLD9&rft_id=info:doi/10.1002/hep.28779&rft_dat=%3Cproquest_cross%3E4287329971%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1852997252&rft_id=info:pmid/27532546&rfr_iscdi=true